Physician profile
Sheila Gonzalez
NPI 1215040894
$11,446.54
in general payments reported to CMS, 2019-2025
48 companies · $2,692 in 2025
The $2,692 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,948 · 2020: $456 · 2021: $915 · 2022: $861 · 2023: $2,333 · 2024: $2,241 · 2025: $2,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,239 · Consulting Fee: $27.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,238.94 |
| Consulting Fee | $27.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,444.55 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $2,004.78 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Lumenis Be INC | $1,260.55 | 2023 | M22 |
| Grifols USA, LLC | $892.90 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Inspire Medical Systems, INC. | $579.97 | 2022-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $456.60 | 2019-2025 | Ofev, Stiolto Respimat |
| Takeda Pharmaceuticals U.S.A., INC. | $401.47 | 2024-2025 | Glassia, Cuvitru |
| Genzyme Corporation | $354.32 | 2019-2025 | |
| Amgen INC. | $345.46 | 2023-2025 | Tezspire |
| Insmed, INC. | $329.50 | 2019-2025 | Arikayce |
| Actelion Pharmaceuticals US, INC. | $270.13 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $241.96 | 2019-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $146.33 | 2024-2025 | Acthar |
| Inogen, INC. | $142.63 | 2021-2025 | Inogen |
| Pacira Pharmaceuticals Incorporated | $124.99 | 2019 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vapotherm INC | $122.84 | 2019 | |
| Electromed, INC. | $122.21 | 2023-2025 | Smartvest |
| Pfizer INC. | $120.86 | 2025 | |
| Acelrx Pharmaceuticals, INC. | $109.19 | 2020 | |
| Merck Sharp & Dohme LLC | $76.33 | 2024-2025 | Winrevair, Keytruda |
| Philips North America LLC | $72.37 | 2024 | (Ak6) Vest Therapy |
| Axsome Therapeutics, INC. | $68.88 | 2024-2025 | Sunosi |
| Mylan Specialty L.P. | $63.50 | 2023 | Yupelri |
| Intuitive Surgical, INC. | $62.97 | 2022 | |
| Pulmonx Corporation | $55.01 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Viatris Specialty LLC | $49.47 | 2025 | Yupelri |
| Sunovion Pharmaceuticals INC. | $38.22 | 2019 | |
| Ambu INC. | $34.18 | 2025 | |
| 3b Medical, INC. | $32.52 | 2024-2025 | Luna |
| Vifor Pharma, INC. | $32.43 | 2025 | Zemaira |
| Shire North American Group INC | $32.28 | 2019 | |
| Baxter Healthcare | $31.89 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Gilead Sciences, INC. | $29.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $29.15 | 2019 | |
| Adma Biomanufacturing LLC | $27.48 | 2025 | |
| Breas Medical, INC. | $24.73 | 2023 | Vivo 45 Ls |
| Lilly USA, LLC | $23.59 | 2025 | Zepbound |
| Csl Behring | $22.82 | 2019 | |
| Paratek Pharmaceuticals, INC. | $20.40 | 2024 | Nuzyra |
| Mallinckrodt Enterprises LLC | $20.22 | 2019 | |
| Fisher & Paykel Healthcare INC | $18.77 | 2024 | Fisher & Paykel Healthcare |
| Genentech USA, INC. | $18.58 | 2019 | |
| Gc Biopharma USA, INC. | $18.46 | 2025 | Alyglo |
| Tactile Systems Technology INC | $17.39 | 2025 | Nimbl, Flexitouch Plus |
| Verona Pharma, INC. | $15.16 | 2025 | Ohtuvayre |
| E.R. Squibb & Sons, L.L.C. | $13.72 | 2019 | |
| Scpharmaceuticals INC. | $13.49 | 2025 | |
| Allergan, INC. | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.